Bristol-Myers Blood Thinner Patent Invalidated In UK
A London judge ruled Thursday that a Bristol-Myers Squibb patent for its blockbuster blood thinner is invalid, siding with Teva Pharmaceutical Industries Ltd. and Sandoz Ltd. in their arguments that the...To view the full article, register now.
Already a subscriber? Click here to view full article